WVE Wave Life Sciences Ltd

Wave Life Sciences Ltd is a preclinical therapeutics developer in Singapore. Its pipeline of drugs is intended to cure rare genetic disorders such as Huntington, duchenne muscular dystrophy (DMD) and inflammatory bowel disease.

$3.25
As of 06/30/2022     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  Singapore
IPO date:  11/11/2015
Outstanding shares:  61,249,222
Average volume:  736,410
Market cap:   $155,573,024
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BYZG9R0

---

Valuation   (See tab for details)

---

PE ratio:   -1.51
PB ratio:   5.34
PS ratio:   3.64
Return on equity:   221,877.36%
Net income %:   -275.31%